← 返回

γδ T 细胞在癌症进展和治疗中的作用

英文原题:Role of γδ T Cells in Cancer Progression and Therapy.

查看英文原题

Role of γδ T Cells in Cancer Progression and Therapy.

PubMed 2023/01/01(内容时间) Crit Rev Oncog

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

γδ T细胞是一类基础免疫细胞,早期即浸润肿瘤,参与对抗癌细胞。随着癌症进展,γδ T细胞的积聚凸显其重要性。最初,这些细胞浸润肿瘤组织并发挥细胞毒性作用。然而,在后期,γδ T细胞的主要表型在多种癌症中发生变化,促进肿瘤生长和转移。癌细胞诱导的不同机制抑制γδ T细胞的效应功能,有时甚至促进癌症进展。在早期阶段,阻断这一机制可消除这一挑战,使γδ T细胞能够有效清除癌细胞。在此背景下,深入探究γδ T细胞在肿瘤微环境中的功能机制变得至关重要。本综述讨论了γδ T细胞在不同癌症类型中的作用。

展开英文摘要原文

γδ T cells signify a foundational group of immune cells that infiltrate tumors early on, engaging in combat against cancer cells. The buildup of γδ T cells as cancer advances underscores their significance. Initially, these cells infiltrate and enact cytotoxic effects within the tumor tissue.

However, in later stages, the predominant phenotype of γδ T cells undergoes changes in numerous cancers, fostering tumor growth and metastasis. Different mechanisms induced by cancer cell suppress effector action of γδ T cells and even sometimes promote cancer progression.

In the early stages, stopping this mechanism clears this challenge and enables γδ T cells to effectively remove cancer cells. Given this context, it becomes imperative to delve into the mechanisms of how γδ T cells function in tumor microenvironment. This review discusses γδ T cells' role across different cancer types.

论文信息

作者
Padmaraju V、Sankla Y、Malla RR
第一作者单位
Department of Biochemistry and Bioinformatics, GITAM School of Science, Department of Biochemistry and Bioinformatics, GITAM School of Science (GSS), GITAM (Deemed to be University), Visakhapatnam, Andhra Pradesh, 530045, India.India
通讯作者单位
Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, School of Science, Gandhi Institute of Technology and Management (GITAM) (Deemed to be University), Visakhapatnam-530045, Andhra Pradesh, India; Department of Biochemistry and Bioinformatics, School of Science, GITAM (Deemed to be University), Visakhapatnam-530045, Andhra Pradesh, India.India
文献类型
综述 · 非美国政府资助研究
期刊
Critical reviews in oncogenesis2023
原文标识
PubMed 38050982 · DOI 10.1615/CritRevOncog.2023050067